Method of Gene Delivery in Large Animal Models of Cardiovascular Diseases

Methods in Molecular Biology

Volumn 709, Issue , 2011, Pages 355-367

  Kawase, Yoshiaki ^a   Ladage, Dennis ^a   Hajjar, Roger J ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Cardiovascular diseases; Clinical application; Gene therapy; Minimally invasive; Viral vectors

Indexed keywords

MICROSPHERE;

ADENO ASSOCIATED VIRUS; ANIMAL; ARTICLE; CARDIOVASCULAR DISEASE; DISEASE MODEL; GENE THERAPY; GENE TRANSFER; GENE VECTOR; GENETICS; HEART CATHETERIZATION; HEART SURGERY; INJECTION; METHODOLOGY;

ANIMALS; CARDIAC SURGICAL PROCEDURES; CARDIOVASCULAR DISEASES; DEPENDOVIRUS; DISEASE MODELS, ANIMAL; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HEART CATHETERIZATION; INJECTIONS; MICROSPHERES;

EID: 79960061266     PISSN: 10643745     EISSN: 19406029     Source Type: Book Series    
DOI: 10.1007/978-1-61737-982-6_23     Document Type: Chapter

References (20)

1. Logeart, D., Hatem, S.N., Heimburger, M., Le Roux, A., Michel, J.B., Mercadier, J.J. (2001) How to optimize in vivo gene transfer to cardiac myocytes: mechanical or pharmacological procedures? Hum Gene Ther 12, 1601–1610.
2. Suzuki, G., Lee, T.C., Fallavollita, J.A., Canty, J.M, Jr. (2005) Adenoviral gene transfer of FGF-5 to hibernating myocardium improves function and stimulates myocytes to hypertrophy and reenter the cell cycle. Circ Res 96, 767–775.
3. Lai, N.C., Roth, D.M., Gao, M.H., et al. (2000) Intracoronary delivery of adenovirus encoding adenylyl cyclase VI increases left ventricular function and cAMP-generating capacity. Circulation 102, 2396–2401.
4. Hayase, M., Del Monte, F., Kawase, Y., et al. (2005) Catheter-based antegrade intracoronary viral gene delivery with coronary venous blockade. Am J Physiol Heart Circ Physiol 288, H2995–H3000.
5. Kaye, D.M., Preovolos, A., Marshall, T., et al. (2007) Percutaneous cardiac recirculation-mediated gene transfer of an inhibitory phos-pholamban peptide reverses advanced heart failure in large animals. J Am Coll Cardiol 50, 253–260.
6. Preovolos, A.C., Mennen, M.T., Bilney, A., Mariani, J., Kaye, D.M., Power, J.M. (2006) Development of a novel perfusion technique to allow targeted delivery of gene therapy – the V-Focus system. J Extra Corpor Technol 38, 51–52.
7. Raake, P.W., Hinkel, R., Muller, S., et al. (2008) Cardio-specific long-term gene expression in a porcine model after selective pressure-regulated retroinfusion of adeno-associated viral (AAV) vectors. Gene Ther 15, 12–17.
8. Raake, P., von Degenfeld, G., Hinkel, R., et al. (2004) Myocardial gene transfer by selective pressure-regulated retroinfusion of coronary veins: comparison with surgical and percutaneous intramyocardial gene delivery. J Am Coll Cardiol 44, 1124–1129.
9. Muller, O.J., Katus, H.A., Bekeredjian, R. (2007) Targeting the heart with gene thera-py-optimized gene delivery methods. Cardiovasc Res 73, 453–462.
10. Smits, P.C., van Langenhove, G., Schaar, M., et al. (2002) Efficacy of percutaneous intramyocardial injections using a nonfluoroscopic 3-D mapping based catheter system. Cardiovasc Drugs Ther 16, 527–533.
11. Kornowski, R., Leon, M.B., Fuchs, S., et al. (2000) Electromagnetic guidance for catheter-based transendocardial injection: a platform for intramyocardial angiogenesis therapy. Results in normal and ischemic porcine models. J Am Coll Cardiol 35, 1031–1039.
12. Hoshino, K., Kimura, T., De Grand, A.M., Yoneyama, R., Kawase, Y., Houser, S., Ly, Q.H., Kushibiki, T., Kurukawa, Y., Ono, K., Tabata, Y., Frangioni, J.V., Kita, T., Hajjar, R.J., Hayase, M. (2006) Three catheter-based strategies for cardiac delivery of therapeutic gelatin microspheres. Gene Ther 13, 1320–1327.
13. Anderl, J.N., Robey, T.E., Stayton, P.S., Murry, C.E. (2009) Retention and biodistribution of microspheres injected into ischemic myocardium. J Biomed Mater Res A 88, 704–710.
14. Grossman, P.M., Han, Z., Palasis, M., Barry, J.J., Lederman, R.J. (2002) Incomplete retention after direct myocardial injection. Catheter Cardiovasc Interv 55, 392–397.
15. Xiao, Y.F., Sigg, D.C., Ujhelyi, M.R., Wilhelm, J.J., Richardson, E.S., Iaizzo, P.A. (2008) Pericardial delivery of omega-3 fatty acid: a novel approach to reducing myocardial infarct sizes and arrhythmias. Am J Physiol Heart Circ Physiol 294, H2212–H2218.
16. Vassalli, G., Bueler, H., Dudler, J., von Segesser, L.K., Kappenberger, L. (2003) Adeno-associated virus (AAV) vectors achieve prolonged transgene expression in mouse myocardium and arteries in vivo: a comparative study with adenovirus vectors. Int J Cardiol 90, 229–238.
17. Sosa, E., Scanavacca, M., d’Avila, A., Oliveira, F., Ramires, J.A. (2000) Nonsurgical transtho-racic epicardial catheter ablation to treat recurrent ventricular tachycardia occurring late after myocardial infarction. J Am Coll Cardiol 35, 1442–1449.
18. Hou, D., March, K.L. (2003) A novel percutaneous technique for accessing the normal pericardium: a single-center successful experience of 53 porcine procedures. J Invasive Cardiol 15, 13–17.
19. d’Avila, A., Neuzil, P., Thiagalingam, A., et al. (2007) Experimental efficacy of pericardial instillation of anti-inflammatory agents during percutaneous epicardial catheter ablation to prevent postprocedure pericarditis. J Cardiovasc Electrophysiol 18, 1178–1783.
20. Weaver, M.E., Pantely, G.A., Bristow, J.D., Ladley, H.D. (1986) A quantitative study of the anatomy and distribution of coronary arteries in swine in comparison with other animals and man. Cardiovasc Res 20, 907–917.